ClinicalTrials.gov record
Completed No phase listed Observational Results available

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

ClinicalTrials.gov ID: NCT02732210

Public ClinicalTrials.gov record NCT02732210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 2:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice

Study identification

NCT ID
NCT02732210
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Amgen
Industry
Enrollment
935 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2011
Primary completion
Apr 6, 2014
Completion
Apr 13, 2014
Last update posted
Nov 28, 2022

2011 – 2014

United States locations

U.S. sites
60
U.S. states
27
U.S. cities
60
Facility City State ZIP Site status
Research Site Birmingham Alabama 35205
Research Site Chandler Arizona 85224
Research Site Peoria Arizona 85381
Research Site Phoenix Arizona 85050
Research Site Hemet California 92543
Research Site Laguna Hills California 92653
Research Site Los Angeles California 90048
Research Site Murrieta California 92563
Research Site Oxnard California 93030
Research Site Santa Maria California 93454
Research Site Santa Monica California 90404
Research Site South Lake Tahoe California 96150
Research Site Victorville California 92395
Research Site Lakewood Colorado 80227
Research Site Trumbull Connecticut 06611
Research Site Fort Myers Florida 33912
Research Site Hollywood Florida 33021
Research Site Jacksonville Florida 32258
Research Site Kissimmee Florida 34741
Research Site Pembroke Pines Florida 33028
Research Site Sebring Florida 33870
Research Site Atlanta Georgia 30342
Research Site Gainesville Georgia 30501
Research Site Woodstock Georgia 30189
Research Site Alton Illinois 62002
Research Site Rockford Illinois 61103
Research Site Bettendorf Iowa 52722
Research Site Detroit Michigan 48236
Research Site East Lansing Michigan 48823
Research Site Lansing Michigan 48910
Research Site Woodbury Minnesota 55125
Research Site Springfield Missouri 65807
Research Site Las Vegas Nevada 89146
Research Site Butler New Jersey 07405
Research Site Dover New Jersey 07801
Research Site Albuquerque New Mexico 87106
Research Site Brooklyn New York 11201
Research Site Plainview New York 11803
Research Site Asheboro North Carolina 27203
Research Site Charlotte North Carolina 28210
Research Site Tabor City North Carolina 28463
Research Site Winston-Salem North Carolina 27103
Research Site Akron Ohio 44313
Research Site Centerville Ohio 45459
Research Site Cincinnati Ohio 45236
Research Site Middletown Ohio 45044
Research Site Bend Oregon 97701
Research Site Duncansville Pennsylvania 16635
Research Site Lansdale Pennsylvania 19446
Research Site Myrtle Beach South Carolina 29572
Research Site Jackson Tennessee 38305
Research Site Austin Texas 78731
Research Site Southlake Texas 76092
Research Site Chesapeake Virginia 23321
Research Site Midlothian Virginia 23114
Research Site Winchester Virginia 22601
Research Site Spokane Washington 99204
Research Site Charleston West Virginia 25304
Research Site Glendale Wisconsin 53217
Research Site Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02732210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2022 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02732210 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →